🇺🇸 FDA
Patent

US 8314125

Bicyclic derivatives as modulators of ion channels

granted A61PA61P1/04A61P13/00

Quick answer

US patent 8314125 (Bicyclic derivatives as modulators of ion channels) held by Vertex Pharmaceuticals Incorporated expires Mon Nov 15 2032 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Vertex Pharmaceuticals Incorporated
Grant date
Tue Nov 20 2012 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Nov 15 2032 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
30
CPC classes
A61P, A61P1/04, A61P13/00, A61P19/02, A61P23/00